Cypress Capital »

Atyr Pharma shares owned by Cypress Capital

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Cypress Capital from 13F filings

Historical chart of Cypress Capital investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Cypress Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Cypress Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $312 200 1.56

More positions owned by Cypress Capital

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Index Fds Total Stk Mkt (VTI)
Wisdomtree Tr Floatng Rat Trea (USFR)
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr TRS FLT RT BD (TFLO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Ishares Tr Hdg Msci Eafe (HEFA)
Apple (AAPL)
Proshares Tr S&p 500 Dv Arist (NOBL)
Cisco Systems (CSCO)
Merck & Co (MRK)
Qualcomm (QCOM)

View all positions for Cypress Capital

Top funds holding Atyr Pharma

Federated Investors
FMR
Logos Global Management
Vanguard Group
Tikvah Management
Checkpoint Capital
Alyeska Investment Group
Citadel Advisors
Woodline Partners
BlackRock
Renaissance Technologies
Ghost Tree Capital
Tang Capital Management
Geode Capital Management
GSA Capital Partners

View all funds holding Atyr Pharma